Samir Devani
Analyst
Analyst — RBC Securities
Earnings-call appearances
-
Conference call to review topline data from the SERENITY At-Home Pivotal Phase 3 trial evaluating the safety of BXCL5012025-08-27
BioXcel Therapeutics, Inc. (BTAI)
-
Valneva SE Q1 FY2025 Earnings Call2025-03-31
Valneva SE (VALN)
-
Valneva SE Q4 FY2024 Earnings Call2024-12-31
Valneva SE (VALN)
-
BioXcel Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-14
BioXcel Therapeutics, Inc. (BTAI)
-
Valneva SE Q3 FY2024 Earnings Call2024-09-30
Valneva SE (VALN)
-
BioXcel Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-09
BioXcel Therapeutics, Inc. (BTAI)
-
BioXcel Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-12
BioXcel Therapeutics, Inc. (BTAI)
-
Valneva SE Q4 FY2023 Earnings Call2023-12-31
Valneva SE (VALN)
-
Valneva SE Q3 FY2023 Earnings Call2023-09-30
Valneva SE (VALN)
-
BioXcel Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-14
BioXcel Therapeutics, Inc. (BTAI)
-
Valneva SE Q2 FY2023 Earnings Call2023-06-30
Valneva SE (VALN)
-
Valneva SE Q1 FY2023 Earnings Call2023-03-31
Valneva SE (VALN)
-
BioXcel Therapeutics, Inc. Q4 FY2022 Earnings Call2023-03-09
BioXcel Therapeutics, Inc. (BTAI)
-
Valneva SE Q4 FY2022 Earnings Call2022-12-31
Valneva SE (VALN)
-
Valneva SE Q3 FY2022 Earnings Call2022-09-30
Valneva SE (VALN)
-
Valneva SE Q1 FY2022 Earnings Call2022-03-31
Valneva SE (VALN)
-
Valneva SE Q4 FY2021 Earnings Call2021-12-31
Valneva SE (VALN)